Collaborations

HYpharm GmbH

HYpharm GmbH and a DZIF-funded consortium are collaborating on the production and development of the phage lysine protein HY…

ICE-HBV

The "International Coalition to Eliminate HBV", or ICE-HBV, has the ambitious goal of eliminating chronic hepatitis B as a…

IDT Biologika

Together with the company IDT Biologika, the DZIF is developing a vaccine against the MERS coronavirus in a consortium of…

INCATE - Incubator for Antimicrobial Therapies in Europe

Multi-resistant bacteria are spreading worldwide. New antibiotics and strategies against deadly infectious diseases are…

Jena University Hospital

Our associated partner Mathias Pletz at Jena University Hospital is involved in the DZIF research area Novel Antibiotics and…

Kumasi Centre for Collaborative Research (KCCR)

Research foci of the "Kumasi Centre for Collaborative Research in Tropical Medicine" (KCCR) in Ghana are malaria…

Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (HKI)

The Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (HKI) in Jena is…

Leipzig University

Leipzig University participates in the DZIF research area Hepatitis through Prof. Dr. Florian van Bömmel as an associated…

Max Delbrück Center for Molecular Medicine

The Berlin Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association is part of a project in the DZIF…

McMaster University

McMaster University is among Canada’s most research-intensive universities and is consistently ranked in the top 20 in the…